2023 annual financial data
Alzamend Neuro 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -14,870,466 USD and net income was -14,878,167 USD.
Operating cash flow was -8,923,152 USD.
Get free Alzamend Neuro email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,870,466 USD
- Net income
- -14,878,167 USD
- Operating cash flow
- -8,923,152 USD